Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer

Colorectal cancer with peritoneal metastases is currently treated by cytoreductive surgery and locoregional chemotherapeutics. This standard treatment is associated with high morbidity, mortality, and recurrence rate. To augment the existing therapy, we developed a liposome-based delivery system con...

Cijeli opis

Bibliografski detalji

Glavni autori:	Griffin Pauli, Po-Han Chao, Zhu Qin, Roland Böttger, Suen Ern Lee, Shyh-Dar Li
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2021-10-01
Serija:	Pharmaceutics
Teme:	liposomes drug delivery resiquimod peritoneal metastasis of cancer immunotherapy toll-like receptor agonist
Online pristup:	https://www.mdpi.com/1999-4923/13/10/1696
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!